Restara Medical, Inc. — SEC Form D Filing

Restara Medical, Inc. filed an SEC Form D on September 23, 2026, reporting $500K raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
September 23, 2026
Amount reported
$500K
Industry
Medical Devices
Website
https://www.restoramedical.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Sleep Apnea is a condition that requires therapy.

Solution

Restora Medical provides a therapy for sleep apnea using targeted nerve stimulation.

Verdict

This pre-seed round cleared because it presented a tangible, device-based approach to a well-understood chronic condition, not because it articulated a novel market entry strategy or clear economic advantage. Investors were implicitly betting on the company’s ability to navigate clinical trials and regulatory pathways for a known medical problem, assuming a future reimbursement landscape would emerge. The upside was limited by the significant capital and time required for medical device development, suggesting this was an early de-risking bet rather than a high-growth speculation.

Source: SEC EDGAR Form D filing